Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002401044 | SCV002705381 | pathogenic | Hereditary cancer-predisposing syndrome | 2018-11-16 | criteria provided, single submitter | clinical testing | The c.161dupT pathogenic mutation, located in coding exon 2 of the PTEN gene, results from a duplication of T at nucleotide position 161, causing a translational frameshift with a predicted alternate stop codon (p.R55Kfs*8). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. |